Relationship between sleep disorders and the risk for developing type 2 diabetes mellitus

Postgraduate Medicine

Volumn 124, Issue 4, 2012, Pages 119-129

  Ioja, Simona ^a   Weir, Ian D ^a   Rennert, Nancy J ^a,b,c  

^a NORWALK HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Continuous positive airway pressure; Obstructive sleep apnea; Sleep; Sleep disorders; Type 2 diabetes mellitus

Indexed keywords

ARTICLE; DISEASE ASSOCIATION; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HOMEOSTASIS; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; RESTLESS LEGS SYNDROME; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SHIFT WORKER; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP TIME; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METABOLISM; REVIEW; RISK;

BLOOD GLUCOSE; CONTINUOUS POSITIVE AIRWAY PRESSURE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; HUMANS; PREVALENCE; RISK; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; SLEEP DISORDERS;

EID: 84871690465     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2012.07.2573     Document Type: Article

References (102)

1. Institute of Medicine. Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem. Washington, DC: The National Academies Press; 2006. http://books.nap.edu/openbook.php?record_ id=11617. Accessed April 2012.
2. US Department of Health and Human Services, Centers for Disease Control and Prevention, 2011. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011. pdf. Accessed April 2012.
3. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5(2):136-143.
4. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. BMJ. 2000; 320(7233):479-482.
5. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378-1384.
6. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnea: a long-term follow-up. Eur Respir J. 2006;28(3):596-602.
7. Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009;6(8):e1000132.
8. Einhorn D, Stewart DA, Erman MK, Gordon N, Philis-Tsimikas A, Casal E. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract. 2007;13(4):355-362.
9. Schober AK, Neurath MF, Harsch IA. Prevalence of sleep apnoea in diabetic patients. Clin Respir J. 2011;5(3):165-172.
10. Foster GD, Sanders MH, Millman R, et al; Sleep AHEAD Research Group. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care. 2009;(6):1017-1019.
11. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002;165(5):677-682.
12. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165(5):670-676.
13. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R Resnick HE; Sleep Heart Health Study Investigators. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol. 2004;160(6):521-530.
14. Reichmuth KJ, Austin D, Skatrud J, Young T. Association of sleep apnea and type II diabetes: a population based study. Am J Respir Crit Care Med. 2005;172(12):1590-1595.
15. Botros N, Concato J, Mohsenin V, Selim B. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med. 2009;122(12):1122-1127.
16. Marshall NS, Wong KK, Phillips CL, Liu PY, Knuiman MW, Grunstein RR. Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study? J Clin Sleep Med. 2009;5(1):15-20.
17. Muraki I, Tanigawa T, Yamagishi K, et al; CIRCS Investigators. Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS). Diabetologia. 2010;53(3):481-488.
18. Ronksley PE, Hemmelgarn BR, Heitman SJ, et al. Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax. 2009; 64(10):834-839.
19. Barceló A, Barbé F, de la Peña M, et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax. 2008;63(11): 946-950.
20. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol. 2009;106(5):1538-1544.
21. Iiyori N, Alonso J, Li J, et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med. 2007;175(8):851-857.
22. Stamatakis K, Punjabi NM. Effects of experimental sleep fragmentation on glucose metabolism in normal subjects. Chest. 2010;137(1):95-101.
23. Idris I, Hall A, O'Reilley J, et al. Obstructive sleep apnoea in patients with type 2 diabetes: aetiology and implications for clinical care. Diabetes Obes Metab. 2009;11(8):733-741.
24. Lui MM, Ip MS. Disorders of glucose metabolism in sleep-disordered breathing. Clin Chest Med. 2010;31(2):271-285.
25. Levy P, Bonsignore MR, Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J. 2009;34(1):243-260.
26. Tasali E, Mokhlesi B, Cauter EV Obstructive sleep apnea and type 2 diabetes. Interacting epidemics. Chest. 2008;133(2):496-506.
27. Bonsignore MR, Eckel J. ERS Meeting Report. Metabolic aspects of obstructive sleep apnoea syndrome. Eur Respir Rev. 2009; 18(112): 113-124.
28. Yokoe T, Alonso LC, Romano LC. Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J Physiol. 2008;586(3):899-911.
29. Xu J, Long YS, Gozal D. Beta-cell death and proliferation after intermittent hypoxia: role of oxidative stress. Free Radic Biol Med. 2009;46(6):783-790.
30. Punjabi NM, Beamer BA. Alterations in glucose disposal in sleep-disordered breathing. Am J Respir Crit Care Med. 2009;179(3): 235-240.
31. Papanas N, Steiropoulos P, Nena E, Tzouvelekis A. HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men. Vasc Health Risk Manag. 2009;5:751-756.
32. Aronsohn RS, Whitmore H, Cauter EV, Tasali E. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med. 2010;181(5):507-513.
33. Yang EH, Hla KM, McHorney CA, Havighurst T, Badr MS, Weber S. Sleep apnea and quality of life. Sleep. 2000;23(4):535-541.
34. D'Ambrosio C, Bowman T, Mohsenin V. Quality of life in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure-a prospective study. Chest. 1999;115(1):123-129.
35. Epstein LJ, Kristo D, Strollo PJ Jr, et al; Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. JCSM. 2009;5(3):263-276.
36. Bazzano L, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50(2):417-423.
37. Siccoli MM, Pepperell JC, Kohler M, Craig SE, Davies RJ, Stradling JR. Effects of continuous positive airway pressure on quality of life in patients with moderate to severe obstructive sleep apnea: data from a randomized controlled trial. Sleep. 2008;31(11):1551-1558.
38. Albarrak M, Banno K, Sabbagh AA, et al. Utilization of healthcare resources in obstructive sleep apnea syndrome: a 5-year follow-up study in men using CPAP. Sleep. 2005;28(10):1306-1311.
39. AlGhanim N, Comondore V, Fleetham J, Marra CA, Ayas NT. The economic impact of obstructive sleep apnea. Lung. 2008;186(1): 7-12.
40. Buchner NJ, Sanner BM, Borgel J, Rump LC. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med. 2007;176(12):1274-1280.
41. Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I, Almeida-Gonzalez C, Catalan-Serra P, Montserrat JM. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment. A cohort study. Ann Intern Med. 2012;156(2):115-122.
42. Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab. 1994;79(6):1681-1685.
43. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients withsevere obstructive sleep apnea and metabolic syndrome. Chest. 2008;134(4):686-692.
44. Hassaballa HA, Tulaimat A, Herdegen JJ, Mokhlesi B. The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep Breath. 2005;9(4): 176-180.
45. Pallayova M, Donic V, Tomori Z. Beneficial effects of severe sleep apnea therapy on nocturnal glucose control in persons with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2008;81(1):e8-e11.
46. Babu AR, Herdegen J, Fogelfeld L, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med. 2005;165(4):447-452.
47. Steiropoulos P, Papanas N, Nena E, Tsara V. Markers of glycemic control and insulin resistance in non-diabetic patients with obstructive sleep apnea hypopnea syndrome: does adherence to CPAP treatment improve glycemic control? Sleep Med. 2009;10(8):887-891.
48. Lam JC, Lam B, Yao TJ, et al. A randomized controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnea. Eur Respir J. 2010;35(1):138-145.
49. West S, Nicoll DJ, Wallace TM, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax. 2007;62(11):969-974.
50. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J. 2007;29(40):720-727.
51. Punjabi NM; Workshop Participants. Do sleep disorders and associated treatments impact glucose metabolism? Drugs. 2009; 69(suppl 2):13-27.
52. Patruno V, Aiolfi S, Costantino G, et al. Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea. Chest. 2007;131(5):1393-1399.
53. Weinstock TG, Wang X, Rueschman M, et al. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep. 2012;35(5):617B-625B.
54. Shpirer I, Rapoport MJ, Stav D, Elizur M. Normal and elevated HbAlc levels correlate with severity of hypoxemia in patients with obstructive sleep apnea and decrease following CPAP treatment. Sleep Breath. 2012;16(2):461-466.
55. Yang D, Liu Z, Yang H, Luo Q. Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis [published online ahead of print March 13, 2012]. Sleep Breath.
56. Hecht L, Möhler R, Meyer G. Effects of CPAP-respiration on markers of glucose metabolism in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis. Ger Med Sci. 2011;Doc20.
57. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977-986.
58. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321(7259):405-412.
59. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-1589.
60. Duckworth W, Abraira C, Moritz T, et al; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129-139.
61. Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24): 2545-2559.
62. ADVANCE Collaborative Group; Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-2572.
63. Metaanalysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141(6):421-431.
64. World Health Organization. WHO fact sheets on diabetes. http://www. who.int/mediacentre/factsheets/fs312/en/index.html. Accessed April 2012.
65. Kosseifi S, Bailey B, Price R, Peiris AN. The association between obstructive sleep apnea syndrome and microvascular complications in well-controlled diabetic patients. Mil Med. 2010;175(11):913-916.
66. Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 2008;31(8):1071-1078.
67. Shaw J, Punjabi NM, Wilding J, Zimmet PZ; International Diabetes Federation Taskforce on Epidemiology and Prevention. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract. 2008;81(1):2-12.
68. American Diabetes Association. Standards of Medical Care in Diabetes-2012. Diabetes Care. 2012;35(suppl 1):S11-S63.
69. Knutson KL, Van Cauter E, Rathouz PJ, DeLeire T, Lauderdale DS. Trends in the prevalence of short sleepers in the USA: 1975-2006. Sleep. 2010;33(1):37-45.
70. Centers for Disease Control and Prevention. National Center for Health Statistics. QuickStats. Percentage of adults who reported an average of £ 6h of sleep per 24-hour period, by sex and age group-United States, 1985 and 2004. http://www.cdc.gov/mmwr/preview/mmwrhtml/ mm5437a7.htm. Accessed April 2012.
71. National Sleep Foundation. 2009 Sleep in America™ Poll: Summary of Findings. Washington, DC: National Sleep Foundation; 2009.
72. Gottlieb DJ, Punjabi NM, Newman AB, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med. 2005;165(8):863-868.
73. Ayas NT, White DP, Al-Delaimy WK, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care. 2003;26(2):380-384.
74. Gangwisch JE, Heymsfield SB, Boden-Albala B. Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep. 2007;30(12):1667-1673.
75. Tuomilehto H, Peltonen M, Partinen M, et al. Sleep duration is associated with an increased risk for the prevalence of type 2 diabetes in middle-aged women-The FIN-D2D survey. Sleep Med. 2008;9(3): 221-227.
76. Mallon L, Broman JE, Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care. 2005;28(11): 2762-2767.
77. Cappuccio F, D'Elia L, Strazzulio P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33(2):414-420.
78. Knutson KL, Ryden AM, Mander BA, Van Cauter E. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med. 2006;166(16):1768-1774.
79. Spiegel K, Leproult R, Cauter EV Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435-1439.
80. Knutson K, Spiegel K, Penev P, Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev. 2007;11(3):163-178.
81. Zizi F, Jean-Louis G, Brown CD, Ogedegbe G, Boutin-Foster C, McFarlane SI. Sleep duration and the risk of diabetes mellitus: epidemiologic evidence and pathophysiologic insights. Curr Diab Rep. 2010;10(1):43-47.
82. Stranges S, Dorn JM, Shipley MJ. Correlates of short and long sleep duration: a cross-cultural comparison between the United Kingdom and the United States: the Whitehall II Study and the Western New York Health Study. Am J Epidemiol. 2008;168(12):1353-1364.
83. Wang XS, Armstrong ME, Cairns BJ, Key TJ, Travis RC. Shift work and chronic disease: the epidemiological evidence. Occup Med (Lond). 2011;61(2):78-89.
84. Pietroiusti A, Neri A, Somma G, et al. Incidence of metabolic syndrome among night-shift healthcare workers. Occup Environ Med. 2010;67(1):54-57.
85. Lin YC, Hsiao TJ, Chen PC. Persistent rotating shift-work exposure accelerates development of metabolic syndrome among middle-aged female employees: a five-year followup. Chronobiol Int. 2009; 26(4):740-755.
86. Lin YC, Hsiao TJ, Chen PC. Shift work aggravates metabolic syndrome development among early-middle-aged males with elevated ALT. World J Gastroenterol. 2009;15(45):5654-5661.
87. Violanti JM, Burchfiel CM, Hartley TA, et al. Atypical work hours and metabolic syndrome among police officers. Arch Environ Occup Health. 2009;64(3):194-201.
88. Mikuni E, Ohoshi T, Hayashi K, Miyamura K. Glucose intolerance in an employed population. Tohoku J Exp Med. 1983;141(suppl): 251-256.
89. Nagaya T, Yoshida H, Takahashi H, Kawai M. Markers of insulin resistance in day and shift workers aged 30-59 years. Int Arch Occup Environ Health. 2002;75(8):562-568.
90. Karlsson B, Alfredsson L, Knutsson A, Andersson E, Toren K. Total mortality and cause-specific mortality of Swedish shift- and day workers in the pulp and paper industry in 1952-2001. Scand J Work Environ Health. 2005;31(1):30-35.
91. Pan A, Schernhammer ES, Sun Q, Hu FB. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLos Med. 2011;8:e1001141.
92. Buxton O, Cain S, O'Connor SP. Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med. 2012;4(129):1-10.
93. Walters A. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Move Disord. 1995;10(5):634-642.
94. Clemens S, Rye D, Hochman S. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology. 2006;67(1):125-130.
95. Skomro RP, Ludwig S, Salamon E, Kryger MH. Sleep complaints and restless legs syndrome in adult type 2 diabetics. Sleep Med. 2001;2:417-422.
96. Phillips B, Hening W, Britz P, Mannino D. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest. 2006;129(1):76-80.
97. Lopes L, Lins Cde MM, Adeodato V Restless legs syndrome and quality of sleep in type 2 diabetes. Diabetes Care. 2005;28(11):2633-2636.
98. Merlino G, Valente M, Serafini A, et al. Effects of restless legs syndrome on quality of life and psychological status in patients with type 2 diabetes mellitus. Diabetes Educ. 2010;36(1):79-87.
99. Merlino G, Fratticci L, Valente M. Association of restless legs syndrome in type 2 diabetes: a case-control study. Sleep. 2007;30(7):866-871.
100. Cuellar NG, Ratcliff SJ. A comparison of glycemic control, sleep, fatigue and depression in type 2 diabetes with and without restless legs syndrome. JCSM. 2008;4(1):50-56.
101. Luyster FS, Dunbar-Jacob J. Sleep quality and quality of life in adults with type 2 diabetes. Diabetes Educ. 2011;37(3):347-355.
102. Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep. 2009;32(5):589-597.